Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,901 | 65,294 | 89,202 | 87,923 | 42,559 |
| Marketable Securities | 68,921 | 65,586 | 31,631 | 60,961 | 155,478 |
| Receivables | 3,654 | 2,031 | 1,168 | 1,618 | 511 |
| Inventories | 5,170 | 0 | N/A | N/A | N/A |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 182 |
| TOTAL | $141,730 | $135,614 | $125,968 | $153,501 | $200,573 |
| Non-Current Assets | |||||
| PPE Net | 2,437 | 2,198 | 2,348 | 964 | 937 |
| Investments And Advances | 0 | 0 | 0 | 19,012 | 0 |
| Intangibles | 26,724 | 5,037 | 6,532 | 8,027 | 9,522 |
| Other Non-Current Assets | 813 | 500 | 600 | 1,114 | 2,069 |
| TOTAL | $29,974 | $7,735 | $9,480 | $29,117 | $12,528 |
| Total Assets | $171,704 | $143,349 | $135,448 | $182,618 | $213,101 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,291 | 661 | 287 | 996 | 648 |
| Accrued Expenses | 495 | 5,180 | 5,187 | 3,381 | 1,324 |
| TOTAL | $7,786 | $32,851 | $32,263 | $31,619 | $31,027 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 27,010 | 26,789 | 27,242 | 26,789 |
| Other Non-Current Liabilities | 3,101 | 0 | 0 | 0 | 0 |
| TOTAL | $3,101 | $66,374 | $93,280 | $117,525 | $144,343 |
| Total Liabilities | $10,887 | $99,225 | $125,543 | $149,144 | $175,370 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,641 | 33,502 | 28,343 | 28,227 | 28,103 |
| Common Shares | 41 | 33 | 28 | 28 | 28 |
| Retained earnings | -287,984 | -308,170 | -291,107 | -263,443 | -253,641 |
| Other shareholders' equity | 16 | 21 | 10 | 21 | 2 |
| TOTAL | $160,817 | $44,124 | $9,905 | $33,474 | $37,731 |
| Total Liabilities And Equity | $171,704 | $143,349 | $135,448 | $182,618 | $213,101 |